OBN C-Suite Breakfast Discussion: What do funders value from a People and Culture perspective, when considering an investment?
OBN C-Suite Breakfast Discussion
This edition of our high-level round table discussion event will bring together a group of investment, HR and company leaders to discuss the topic of: 'What do funders value from a People and Culture perspective, when considering an investment?'
Discussion will lead by members of OBN's 'Investment & Tax Advisory Group' and 'People & Culture Advisory Group' including:
Matthew Frohn, Managing Partner & Co-Founder of Longwall Ventures
Angela Hobbs, CEO of Wilkinson Hall, COO of Evelyn Health
Shawn Manning, Chairman of Chronos Therapeutics
Catrin Gaston-Penny, Human Resources Director at the Cell and Gene Therapy Catapult
During the session the group will consider how important company culture & the 'Startup team' is to investors and how it can determine the long term success of the relationship. We will cover topics such as shared values, use of language, how to build trust, the importance of transparency, the relationship to other partners/collaborators and co-investors, as well as the risks involved with not aligning with or understanding organisational cultures.
Event format: OBN's round table C-Suite Discussions are designed exclusively for senior leaders (C-Suite or equivalent) from life sciences organisations, whether R&D or those involved in providing critical support services to the industry. The purpose of these events is to generate some interesting, useful, high-level and boundary pushing discussion and debate, that creates some practical thought-leadership output.
Please note that places are limited and will be offered on an approval only basis.
This event is kindly hosted by ThermoFisher Scientific at their PPD offices in The Ark Building in Hammersmith, London.